Conmed (CNMD) Invested Capital (2010 - 2026)

Conmed (CNMD) has reported Invested Capital for 17 consecutive years, with $1.9 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Invested Capital changed 0.48% year-over-year to $1.9 billion; the trailing twelve-month figure through Jun 2026 stood at $1.9 billion (changed 0.48% YoY), and the FY2025 full-year result was $1.9 billion, changed 0.02% from the prior year.
• Invested Capital held at $1.9 billion in Q2 2026 per CNMD's latest filing, from $1.9 billion in the prior quarter.
• Across five years, Invested Capital topped out at $1.9 billion in Q2 2025 and bottomed at $1.5 billion in Q1 2022.
• Historically, Invested Capital has averaged $1.8 billion across 5 years, with a median of $1.8 billion in 2024.
• The sharpest annual moves came in 2022 and 2025: Invested Capital increased 22.47% in 2022, then declined 0.62% in 2025.
• Over 5 years, Invested Capital stood at $1.8 billion in 2022, then grew by 0.43% to $1.8 billion in 2023, then rose by 3.34% to $1.9 billion in 2024, then declined by 0.02% to $1.9 billion in 2025, then grew by 0.41% to $1.9 billion in 2026.
• According to Business Quant data, Invested Capital over the past three periods registered $1.9 billion, $1.9 billion, and $1.9 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.